{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:10:14Z","timestamp":1759342214333,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803339"],"award-info":[{"award-number":["81803339"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiaxing Science and Technology Project","award":["2018AY32002"],"award-info":[{"award-number":["2018AY32002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00894-022-05125-8","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:02:33Z","timestamp":1654819353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of PRMT5 inhibitors with novel scaffold structures through virtual screening and biological evaluations"],"prefix":"10.1007","volume":"28","author":[{"given":"Qian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaohua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haofeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4119-3219","authenticated-orcid":false,"given":"Fei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,10]]},"reference":[{"key":"5125_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molcel.2008.12.013","volume":"33","author":"MT Bedford","year":"2009","unstructured":"Bedford MT, Clarke SG (2009) Protein arginine methylation in mammals: who, what, and why. Mol Cell 33:1\u201313","journal-title":"Mol Cell"},{"key":"5125_CR2","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/j.febslet.2010.11.010","volume":"585","author":"A Di Lorenzo","year":"2011","unstructured":"Di Lorenzo A, Bedford MT (2011) Histone arginine methylation. FEBS Lett 585:2024\u20132031","journal-title":"FEBS Lett"},{"key":"5125_CR3","doi-asserted-by":"publisher","first-page":"37010","DOI":"10.1074\/jbc.M113.525345","volume":"288","author":"Y Feng","year":"2013","unstructured":"Feng Y, Maity R, Whitelegge JP, Hadjikyriacou A, Li Z, Zurita-Lopez C et al (2013) Mammalian protein arginine methyltransferase 7 (PRMT7) specifically targets RXR sites in lysine- and arginine-rich regions. J Biol Chem 288:37010\u201337025","journal-title":"J Biol Chem"},{"key":"5125_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1517\/13543784.2016.1144747","volume":"25","author":"H Hu","year":"2016","unstructured":"Hu H, Qian K, Ho MC, Zheng YG (2016) Small molecule inhibitors of protein arginine methyltransferases. Expert Opin Investig Drugs 25:335\u2013358","journal-title":"Expert Opin Investig Drugs"},{"key":"5125_CR5","doi-asserted-by":"publisher","first-page":"9630","DOI":"10.1128\/MCB.24.21.9630-9645.2004","volume":"24","author":"S Pal","year":"2004","unstructured":"Pal S, Vishwanath SN, Erdjument-Bromage H, Tempst P, Sif S (2004) Human SWI\/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol Cell Biol 24:9630\u20139645","journal-title":"Mol Cell Biol"},{"key":"5125_CR6","doi-asserted-by":"publisher","first-page":"19114","DOI":"10.1073\/pnas.1009669107","volume":"107","author":"X Deng","year":"2010","unstructured":"Deng X, Gu L, Liu C, Lu T, Lu F, Lu Z et al (2010) Arginine methylation mediated by the Arabidopsis homolog of PRMT5 is essential for proper pre-mRNA splicing. Proc Natl Acad Sci USA 107:19114\u201319119","journal-title":"Proc Natl Acad Sci USA"},{"key":"5125_CR7","doi-asserted-by":"publisher","first-page":"ra58-ra","DOI":"10.1126\/scisignal.2001936","volume":"4","author":"P Andreu-Perez","year":"2011","unstructured":"Andreu-Perez P, Esteve-Puig R, de Torre-Minguela C, Lopez-Fauqued M, Bech-Serra JJ, Tenbaum S et al (2011) Protein arginine methyltransferase 5 regulates ERK1\/2 signal transduction amplitude and cell fate through CRAF. Sci Signal 4:ra58-ra","journal-title":"Sci Signal"},{"key":"5125_CR8","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1038\/emboj.2009.365","volume":"28","author":"KM Nishida","year":"2009","unstructured":"Nishida KM, Okada TN, Kawamura T, Mituyama T, Kawamura Y, Inagaki S et al (2009) Functional involvement of Tudor and dPRMT5 in the piRNA processing pathway in Drosophila germlines. EMBO J 28:3820\u20133831","journal-title":"EMBO J"},{"key":"5125_CR9","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3892\/ijo.2016.3584","volume":"49","author":"M Kanda","year":"2016","unstructured":"Kanda M, Shimizu D, Fujii T, Tanaka H, Shibata M, Iwata N et al (2016) Protein arginine methyltransferase 5 is associated with malignant phenotype and peritoneal metastasis in gastric cancer. Int J Oncol 49:1195\u20131202","journal-title":"Int J Oncol"},{"key":"5125_CR10","doi-asserted-by":"publisher","first-page":"22799","DOI":"10.18632\/oncotarget.4332","volume":"6","author":"B Zhang","year":"2015","unstructured":"Zhang B, Dong S, Zhu R, Hu C, Hou J, Li Y et al (2015) Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3. Oncotarget 6:22799\u201322811","journal-title":"Oncotarget"},{"key":"5125_CR11","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/leu.2015.308","volume":"30","author":"S Tarighat","year":"2016","unstructured":"Tarighat S, Santhanam R, Frankhouser D, Radomska HS, Lai H, Anghelina M et al (2016) The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation. Leukemia 30:789\u2013799","journal-title":"Leukemia"},{"key":"5125_CR12","doi-asserted-by":"publisher","first-page":"17960","DOI":"10.1073\/pnas.1209814109","volume":"109","author":"S Antonysamy","year":"2012","unstructured":"Antonysamy S, Bonday Z, Campbell RM, Doyle B, Druzina Z, Gheyi T et al (2012) Crystal structure of the human PRMT5:MEP50 complex. Proc Natl Acad Sci USA 109:17960\u201317965","journal-title":"Proc Natl Acad Sci USA"},{"key":"5125_CR13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1021\/ml500467h","volume":"6","author":"D Smil","year":"2015","unstructured":"Smil D, Eram MS, Li F, Kennedy S, Szewczyk MM, Brown PJ et al (2015) Discovery of a dual PRMT5-PRMT7 inhibitor. ACS Med Chem Lett 6:408\u2013412","journal-title":"ACS Med Chem Lett"},{"key":"5125_CR14","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1021\/acsmedchemlett.8b00014","volume":"9","author":"ZQ Bonday","year":"2018","unstructured":"Bonday ZQ, Cortez GS, Grogan MJ, Antonysamy S, Weichert K, Bocchinfuso WP et al (2018) LLY-283, a potent and selective inhibitor of arginine methyltransferase 5, PRMT5, with antitumor activity. ACS Med Chem Lett 9:612\u2013617","journal-title":"ACS Med Chem Lett"},{"key":"5125_CR15","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1021\/acs.jcim.8b00050","volume":"58","author":"F Ye","year":"2018","unstructured":"Ye F, Zhang W, Ye X, Jin J, Lv Z, Luo C (2018) Identification of selective, cell active inhibitors of protein arginine methyltransferase 5 through structure-based virtual screening and biological assays. J Chem Inf Model 58:1066\u20131073","journal-title":"J Chem Inf Model"},{"key":"5125_CR16","doi-asserted-by":"publisher","first-page":"9711","DOI":"10.1038\/s41598-018-28002-y","volume":"8","author":"SV Gerhart","year":"2018","unstructured":"Gerhart SV, Kellner WA, Thompson C, Pappalardi MB, Zhang XP, Montes de Oca R et al (2018) Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicing. Sci Rep 8:9711","journal-title":"Sci Rep"},{"key":"5125_CR17","doi-asserted-by":"publisher","first-page":"3648","DOI":"10.1039\/C7OB00070G","volume":"15","author":"Y Ye","year":"2017","unstructured":"Ye Y, Zhang B, Mao R, Zhang C, Wang Y, Xing J et al (2017) Discovery and optimization of selective inhibitors of protein arginine methyltransferase 5 by docking-based virtual screening. Org Biomol Chem 15:3648\u20133661","journal-title":"Org Biomol Chem"},{"key":"5125_CR18","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1182\/blood-2014-12-619783","volume":"125","author":"L Alinari","year":"2015","unstructured":"Alinari L, Mahasenan KV, Yan F, Karkhanis V, Chung JH, Smith EM et al (2015) Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation. Blood 125:2530\u20132543","journal-title":"Blood"},{"key":"5125_CR19","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.2174\/156802607780906753","volume":"7","author":"CN Cavasotto","year":"2007","unstructured":"Cavasotto CN, Orry AJW (2007) Ligand docking and structure-based virtual screening in drug discovery. Curr Top Med Chem 7:1006\u20131014","journal-title":"Curr Top Med Chem"},{"key":"5125_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3\u201326","journal-title":"Adv Drug Deliv Rev"},{"key":"5125_CR21","doi-asserted-by":"publisher","first-page":"797","DOI":"10.4155\/fmc.11.44","volume":"3","author":"A Whitty","year":"2011","unstructured":"Whitty A (2011) Growing PAINS in academic drug discovery. Future Med Chem 3:797\u2013801","journal-title":"Future Med Chem"},{"key":"5125_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.compbiolchem.2018.02.004","volume":"73","author":"WY Jin","year":"2018","unstructured":"Jin WY, Ma Y, Li WY, Li HL, Wang RL (2018) Scaffold-based novel SHP2 allosteric inhibitors design using receptor-Ligand pharmacophore model, virtual screening and molecular dynamics. Comput Biol Chem 73:179\u2013188","journal-title":"Comput Biol Chem"},{"key":"5125_CR23","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","volume":"21","author":"JC Shelley","year":"2007","unstructured":"Shelley JC, Cholleti A, Frye LL, Greenwood JR, Timlin MR, Uchimaya M (2007) Epik: a software program for pK( a ) prediction and protonation state generation for drug-like molecules. J Comput Aided Mol Des 21:681\u2013691","journal-title":"J Comput Aided Mol Des"},{"key":"5125_CR24","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739\u201349","journal-title":"J Med Chem"},{"key":"5125_CR25","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1111\/cbdd.13047","volume":"90","author":"WY Zhang","year":"2017","unstructured":"Zhang WY, Lu WC, Jiang H, Lv ZB, Xie YQ, Lian FL et al (2017) Discovery of alkyl bis(oxy)dibenzimidamide derivatives as novel protein arginine methyltransferase 1 (PRMT1) inhibitors. Chem Biol Drug Des 90:1260\u20131270","journal-title":"Chem Biol Drug Des"},{"key":"5125_CR26","doi-asserted-by":"publisher","first-page":"6289","DOI":"10.1021\/acs.jmedchem.7b00587","volume":"60","author":"R Mao","year":"2017","unstructured":"Mao R, Shao J, Zhu K, Zhang Y, Ding H, Zhang C et al (2017) Potent, Selective, and cell active protein arginine methyltransferase 5 (PRMT5) inhibitor developed by structure-based virtual screening and hit optimization. J Med Chem 60:6289\u20136304","journal-title":"J Med Chem"},{"key":"5125_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/wcms.1121","volume":"3","author":"R Salomon-Ferrer","year":"2013","unstructured":"Salomon-Ferrer R, Case DA, Walker RC (2013) An overview of the Amber biomolecular simulation package. Wiley Interdiscip Rev Comput Mol Sci 3:198\u2013210","journal-title":"Wiley Interdiscip Rev Comput Mol Sci"},{"key":"5125_CR28","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/jcc.20290","volume":"26","author":"DA Case","year":"2005","unstructured":"Case DA, Cheatham TE 3rd, Darden T, Gohlke H, Luo R, Merz KM Jr et al (2005) The Amber biomolecular simulation programs. J Comput Chem 26:1668\u20131688","journal-title":"J Comput Chem"},{"key":"5125_CR29","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25:1157\u20131174","journal-title":"J Comput Chem"},{"key":"5125_CR30","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/jcc.10128","volume":"23","author":"A Jakalian","year":"2002","unstructured":"Jakalian A, Jack DB, Bayly CI (2002) Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. J Comput Chem 23:1623\u201341","journal-title":"J Comput Chem"},{"key":"5125_CR31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","volume":"25","author":"J Wang","year":"2006","unstructured":"Wang J, Wang W, Kollman PA, Case DA (2006) Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model 25:247\u2013260","journal-title":"J Mol Graph Model"},{"key":"5125_CR32","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1021\/ct2002732","volume":"7","author":"D Nayar","year":"2011","unstructured":"Nayar D, Agarwal M, Chakravarty C (2011) Comparison of tetrahedral order, liquid state anomalies, and hydration behavior of mTIP3P and TIP4P water models. J Chem Theory Comput 7:3354\u20133367","journal-title":"J Chem Theory Comput"},{"key":"5125_CR33","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"DR Roe","year":"2013","unstructured":"Roe DR, Cheatham TE 3rd (2013) PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput 9:3084\u20133095","journal-title":"J Chem Theory Comput"},{"issue":"33\u20138","key":"5125_CR34","first-page":"27","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14(33\u20138):27\u201328","journal-title":"J Mol Graph"},{"key":"5125_CR35","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"BR Miller 3rd","year":"2012","unstructured":"Miller BR 3rd, McGee TD Jr, Swails JM, Homeyer N, Gohlke H, Roitberg AE (2012) MMPBSA.py: an efficient program for end-state free energy calculations. J Chem Theory Computation 8:3314\u201321","journal-title":"J Chem Theory Computation"},{"key":"5125_CR36","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0022-2836(03)00610-7","volume":"330","author":"H Gohlke","year":"2003","unstructured":"Gohlke H, Kiel C, Case DA (2003) Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. J Mol Biol 330:891\u2013913","journal-title":"J Mol Biol"},{"key":"5125_CR37","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.bbrc.2017.11.089","volume":"495","author":"K Zhu","year":"2018","unstructured":"Zhu K, Jiang CS, Hu J, Liu X, Yan X, Tao H et al (2018) Interaction assessments of the first S-adenosylmethionine competitive inhibitor and the essential interacting partner methylosome protein 50 with protein arginine methyltransferase 5 by combined computational methods. Biochem Biophys Res Commun 495:721\u2013727","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-022-05125-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00894-022-05125-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-022-05125-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T18:19:51Z","timestamp":1657131591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00894-022-05125-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["5125"],"URL":"https:\/\/doi.org\/10.1007\/s00894-022-05125-8","relation":{},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"type":"print","value":"1610-2940"},{"type":"electronic","value":"0948-5023"}],"subject":[],"published":{"date-parts":[[2022,6,10]]},"assertion":[{"value":"28 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"184"}}